Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K/A | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenue | 1.1 | 3.2 | 3.1 | 3.4 | 3.4 | 3.5 | 3.0 | 2.6 |
| Revenue growth | -66.6% | 3.4% | -10.3% | 0.3% | -1.2% | 16.4% | 14.0% | 6417.5% |
| Costs and expenses: | | | | | | | | |
| Selling, general and administrative | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 |
| Total | 1.1 | 1.6 | 1.6 | 3.3 | 2.7 | 2.6 | 2.4 | 1.9 |
| Operating loss | -0.1 | 1.6 | 1.5 | 0.1 | 0.7 | 0.6 | 0.5 | 0.7 |
| Operating margin | -8.3% | 50.9% | 48.5% | 3.8% | 20.2% | 17.8% | 18.3% | 28.2% |
| |
| Total other expense | | | | | | | | |
| Loss from investments in unconsolidated entities, net | -0.5 | -0.8 | -1.4 | -0.7 | -0.1 | 0.6 | 0.3 | 0.0 |
| Total other expense | -0.5 | -0.8 | | | | | | |
| (Loss) income before income taxes | -0.6 | 0.9 | 0.2 | -0.6 | 0.4 | 0.9 | 0.6 | 0.8 |
| Provision for income taxes | -0.4 | -0.3 | 0.0 | 0.2 | 0.1 | -0.3 | -0.3 | -0.2 |
| Net (loss) income | -1.0 | 0.5 | | | | | | |
| Net loss attributable to noncontrolling interests | 0.1 | | | | | | | |
| Net (loss) income attributable to U.S. Neurosurgical Holdings, Inc. | -0.9 | 0.5 | 0.1 | -0.4 | 0.5 | 0.5 | 0.4 | 0.6 |
| |
| Basic net | ($0.11) | $0.07 | $0.02 | ($0.05) | $0.07 | $0.07 | $0.05 | $0.07 |
| Diluted net | ($0.11) | $0.07 | $0.02 | ($0.05) | $0.07 | $0.07 | $0.05 | $0.07 |
| |
| Weighted average common shares outstanding, basic (in shares) | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
| Weighted average common shares outstanding, diluted (in shares) | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
|